UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 61

Sortiert nach

EZH2 inhibition for epithelioid sarcoma and follicular lymphoma

The lancet oncology, 2020-11, Vol.21 (11), p.1388-1390

2020

Link zum Volltext

Verfügbarkeit prüfen

COVID-19 vaccine guidance for patients with cancer participating in oncology clinical trials

Nature reviews. Clinical oncology, 2021-05, Vol.18 (5), p.313-319

2021

Link zum Volltext

Verfügbarkeit prüfen

Clinical Next-Generation Sequencing for Precision Oncology in Rare Cancers

Molecular cancer therapeutics, 2018-07, Vol.17 (7), p.1595-1601

2018

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of a Gene Expression Profiling Assay in Primary Cutaneous Melanoma

Annals of surgical oncology, 2021-08, Vol.28 (8), p.4582-4589

2021

Link zum Volltext

Verfügbarkeit prüfen

Characteristics and outcomes of patients with advanced sarcoma enrolled in early phase immunotherapy trials

Journal for immunotherapy of cancer, 2017-12, Vol.5 (1), p.100-8, Article 100

2017

Link zum Volltext

Verfügbarkeit prüfen

Cutaneous angiosarcoma: A review of current evidence for treatment with checkpoint inhibitors

Frontiers in medicine, 2023-03, Vol.10, p.1090168-1090168

2023

Link zum Volltext

Verfügbarkeit prüfen

The Role of Next-Generation Sequencing in Sarcomas: Evolution From Light Microscope to Molecular Microscope

Current oncology reports, 2017-12, Vol.19 (12), p.78-8, Article 78

2017

Link zum Volltext

Verfügbarkeit prüfen

Combination Therapies for Precision Oncology: The Ultimate Whack-A-Mole Game

Clinical cancer research, 2021-05, Vol.27 (10), p.2672-2674

2021

Link zum Volltext

Verfügbarkeit prüfen

Use of immune checkpoint inhibitors in solid organ transplant recipients with advanced cutaneous malignancies

Frontiers in transplantation, 2023-10, Vol.2

2023

Link zum Volltext

Verfügbarkeit prüfen

A phase Ib dose-escalation study of troriluzole (BHV-4157), an oral glutamatergic signaling modulator, in combination with nivolumab in patients with advanced solid tumors

European journal of medical research, 2022-07, Vol.27 (1), p.1-7, Article 107

2022

Link zum Volltext

Verfügbarkeit prüfen

Unique Aberrations in Intimal Sarcoma Identified by Next-Generation Sequencing as Potential Therapy Targets

Cancers, 2019-08, Vol.11 (9), p.1283

2019

Link zum Volltext

Verfügbarkeit prüfen

Massive Malignant Epithelioid Angiomyolipoma of the Kidney

Journal of kidney cancer and VHL, 2022-01, Vol.9 (2), p.13-18

2022

Link zum Volltext

Verfügbarkeit prüfen

Author Correction: COVID-19 vaccine guidance for patients with cancer participating in oncology clinical trials

Nature reviews. Clinical oncology, 2021-05, Vol.18 (5), p.320-320

2021

Link zum Volltext

Verfügbarkeit prüfen

Sequencing PEComas: Viewing Unicorns through the Molecular Looking Glass

Oncology, 2021-01, Vol.99 (1), p.62-64

2021

Link zum Volltext

Verfügbarkeit prüfen

Landscape of Immune-Related Markers and Potential Therapeutic Targets in Soft Tissue Sarcoma

Cancers, 2021-10, Vol.13 (20), p.5249

2021

Link zum Volltext

Verfügbarkeit prüfen

Therapy of Angiosarcoma with Thalidomide and Lenalidomide

Case reports in oncology, 2021-11, Vol.14 (3), p.1580-1585

2021

Link zum Volltext

Verfügbarkeit prüfen

Genomic characterization of malignant pleural mesothelioma and associated clinical outcomes

Cancer treatment and research communications, 2020, Vol.25, p.100232-100232, Article 100232

2020

Link zum Volltext

Verfügbarkeit prüfen

535 A phase I/II study of REGN7075 (EGFRxCD28 costimulatory bispecific antibody) in combination with cemiplimab (anti–PD-1) in patients with advanced solid tumors

Journal for immunotherapy of cancer, 2021-11, Vol.9 (Suppl 2), p.A565-A565

2021

Link zum Volltext

Verfügbarkeit prüfen

Phase I study of sapanisertib with carboplatin and paclitaxel in mTOR pathway altered solid malignancies

NPJ precision oncology, 2023-04, Vol.7 (1), p.37-37, Article 37

2023

Link zum Volltext

Verfügbarkeit prüfen

Patient-Centered, Physician-Investigator Friendly Pragmatic Phase Trial Designsd The 4P Model

Mayo Clinic proceedings, 2020-11, Vol.95 (11), p.2566-2568

2020

Link zum Volltext

Verfügbarkeit prüfen

Patient-Centered, Physician-Investigator Friendly Pragmatic Phase I/II Trial Designs—The 4P Model

Mayo Clinic proceedings, 2020-11, Vol.95 (11), p.2566-2568

2020

Link zum Volltext

Verfügbarkeit prüfen

Abstract 2343: Comprehensive evaluation of antibody-drug conjugate targets for drug development across tumor types: Analysis from TCGA

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.2343-2343

2018

Link zum Volltext

Verfügbarkeit prüfen

The big, the bad, and the exon 11: adjuvant imatinib for all gastro-intestinal stromal tumors or just the ugly?

Translational gastroenterology and hepatology, 2017-10, Vol.2 (10), p.81-81

2017

Link zum Volltext

Verfügbarkeit prüfen

Patient-Centered, Physician-Investigator Friendly Pragmatic Phase Trial Designs-The 4P Model

Mayo Clinic proceedings, 2020-11, Vol.95 (11), p.2566-2568

2020

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 61

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(54)
Mit Volltextzugriff
(60)

Publikationsform

Sprache

Englisch
(61)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

EZH2 inhibition for epithelioid sarcoma and follicular lymphoma

COVID-19 vaccine guidance for patients with cancer participating in oncology clinical trials

Clinical Next-Generation Sequencing for Precision Oncology in Rare Cancers

Evaluation of a Gene Expression Profiling Assay in Primary Cutaneous Melanoma

Characteristics and outcomes of patients with advanced sarcoma enrolled in early phase immunotherapy trials

Cutaneous angiosarcoma: A review of current evidence for treatment with checkpoint inhibitors

Genomic landscape of lymphatic malformations: a case series and response to the PI3Kα inhibitor alpelisib in an N-of-1 clinical trial

The Role of Next-Generation Sequencing in Sarcomas: Evolution From Light Microscope to Molecular Microscope

Combination Therapies for Precision Oncology: The Ultimate Whack-A-Mole Game

Use of immune checkpoint inhibitors in solid organ transplant recipients with advanced cutaneous malignancies

A phase Ib dose-escalation study of troriluzole (BHV-4157), an oral glutamatergic signaling modulator, in combination with nivolumab in patients with advanced solid tumors

Unique Aberrations in Intimal Sarcoma Identified by Next-Generation Sequencing as Potential Therapy Targets

Massive Malignant Epithelioid Angiomyolipoma of the Kidney

Author Correction: COVID-19 vaccine guidance for patients with cancer participating in oncology clinical trials

Sequencing PEComas: Viewing Unicorns through the Molecular Looking Glass

Landscape of Immune-Related Markers and Potential Therapeutic Targets in Soft Tissue Sarcoma

Therapy of Angiosarcoma with Thalidomide and Lenalidomide

Genomic characterization of malignant pleural mesothelioma and associated clinical outcomes

535 A phase I/II study of REGN7075 (EGFRxCD28 costimulatory bispecific antibody) in combination with cemiplimab (anti–PD-1) in patients with advanced solid tumors

Phase I study of sapanisertib with carboplatin and paclitaxel in mTOR pathway altered solid malignancies

Patient-Centered, Physician-Investigator Friendly Pragmatic Phase Trial Designsd The 4P Model

Patient-Centered, Physician-Investigator Friendly Pragmatic Phase I/II Trial Designs—The 4P Model

Abstract 2343: Comprehensive evaluation of antibody-drug conjugate targets for drug development across tumor types: Analysis from TCGA

The big, the bad, and the exon 11: adjuvant imatinib for all gastro-intestinal stromal tumors or just the ugly?

Patient-Centered, Physician-Investigator Friendly Pragmatic Phase Trial Designs-The 4P Model

Suchergebnisse filtern